Prostatype Genomics
Business Services · Sweden · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Augustendalsvägen 20, Nacka Strand, Stoc...Phone Number
+46 730497701Website
www.prostatypegenomics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Prostatype Genomics
Prostatype Genomics AB is a company that operates in the Research & Development industry. It employs 5to9 people and has 1Mto5M of revenue. The company is headquartered in Nacka Strand, Stockholm, Sweden.Explore more
Prostatype Genomics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Prostatype Genomics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Prostatype Genomics is spiking on competitors!
Prostatype Genomics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Prostatype Genomics has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Prostatype Genomics launches new products
Earning: See what the market has to say on Prostatype Genomics recently announced quarterly report
Click to see if Prostatype Genomics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Prostatype Genomics
Check if Prostatype Genomics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Prostatype Genomics
Find 3 more new buyers
Company Profile Activity
Activity Insights
Prostatype Genomics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Prostatype Genomics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Prostatype Genomics.
Prostatype Genomics Tech Stack
A closer look at the technologies used by Prostatype Genomics
See more technologies
Most Recent Scoops
Left Company
Executive Move
Left Company
Executive Move
New Hire
Executive Move
Left Company
Executive Move
Left Company
Executive Move
Prostatype Genomics News & Media
Loan financing of SEK 10 million to Prostatype Genomics AB - TradingView
Prostatype Genomics AB (the “Company”) has entered into short-term loan agreements of SEK 6.5 million with major shareholders and SEK 3.5 million with external lenders, with the option of further SEK 2.0 million.The loans carry a fixed interest rate of about 15 percent and shall be repaid, includin…Prostatype Genomics announces outcome of exercise of warrants of series 3 (TO3)
Prostatype Genomics AB ("Prostatype Genomics" or the "Company") today announces the outcome of the exercise period for warrants of series 3 (the "Warrants" or “TO3”) issued in connection with Prostatype Genomics rights issue of units announced on 7 November 2023 (the “Rights Issue”). A total of 202,524,736 Warrants were exercised, of which 20,000,000 by offsetting claims, corresponding to a subscription rate of approximately 81.0 percent. Prostatype Genomics receives proceeds of approximately SEProstatype Genomics announces very strong interim results from long-term follow-up study with Prostatype® in Uppsala
Prostatype Genomics AB ("Prostatype Genomics" or the "Company") announces that interim results from 180 of a total of approximately 500 patients in the ongoing long-term follow-up study at Akademiska University Hospital in Uppsala, Sweden, with the Company's genetic test Prostatype® show excellent accuracy for Prostatype® even after 20 years of follow-up time after diagnosis. None of the analysed patients classified as low risk by Prostatype® died from their prostate cancer during 20 years of foProstatype Genomics updates on significant progress in the US study with Prostatype®
Prostatype Genomics AB (”Prostatype Genomics” or ”the Company”) announces that the US study with Prostatype®, which includes approximately 1,200 patients with prostate cancer with a broad ethnicity coverage, is progressing significantly faster than expected. Approximately 40% of the entire study has already been completed. The Company will compile interim data from the study and apply to get Prostatype® approved for reimbursement in the United States by Medicare when approximately 150 African Am
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Prostatype Genomics
Sign Up For FreeTo access detailed company insights
Prostatype Genomics AB is a company that operates in the Research & Development industry. It employs 5to9 people and has 1Mto5M of revenue. The company is headquartered in Nacka Strand, Stockholm, Sweden.... Read More
